Trump signs executive order aimed at slashing prescription drug costs
President Donald Trump signed an executive order on Monday aimed at slashing prescription drug prices in the U.S. that could lead to the capping of prices at a level equivalent to the cost in similar nations.
The U.S. has paid more than other similarly wealthy countries for prescription drugs for decades, with a 2024 study conducted by the Rand Corporation, a public policy think tank, finding that Americans in general pay 2.78 times more for prescription drugs than 33 other nations.
Under the executive order, Trump will roll out a 'most favored nation' policy which, he hopes, will allow the U.S. to pay for prescription drugs at the same price as 'the Nation at pays the lowest price anywhere in the World.'
'Basically, what we are doing is equalizing,' Trump said during a press conference on Monday. 'We're all going to pay the same.'
The executive order directs the Department of Commerce and the U.S. Trade Representative Jamieson Greer to take 'all appropriate action' against 'unreasonable and discriminatory' policies in foreign countries that suppress drug prices abroad, according to a White House official.
It also directs Health and Human Services Secretary Robert F. Kennedy Jr. to set 'clear targets' for prescription drug and pharmaceutical price reductions within 30 days.
This, Trump hopes, will open a round of negotiations between the agency and the pharmaceutical and prescription drug industries to knock down drug prices.
But if nothing comes of those talks, Kennedy will then impose a 'most favored nation' pricing model capping U.S. prices at the lowest rates paid by other similarly wealthy countries.
The Food and Drug Administration will also consider expanding drug importation from other countries besides Canada where drug prices are often cheaper, White House officials during a phone call to reporters.
The Department of Justice and Federal Trade Commission will enforce anti-competitive actions that contribute to high drug prices in the U.S., White House officials said. The Department of Commerce could also consider export restrictions that enable low pricing abroad, they added.
Trump tried to implement a similar policy to lower drug prices during his first term, which was blocked by a federal judge in 2020. This time around, the policy encompasses a broader set of federal actions.
Trump said that moves will hopefully knock down drug prices by 59 percent, in a post to the social media platform X.
He then added during a press conference Monday that drug prices could be reduced by between '59 and 80 and I guess even 90 percent.'
White House officials did not say which drugs will be subject to price cuts under the policy, but said Americans could expect GLP-1 agonists, which include weight loss drugs like Wegovy, Ozempic and Mounjaro to be among those subject to the plan.
Last month, the Trump administration rejected a Biden-era plan that would have required Medicaid and Medicare to cover the weight loss drugs, which could have expanded access. The plan would have also potentially saved the federal government about $35 billion over 10 years, according to estimates from The Congressional Budget Office.
White House officials said that they expect drug prices to begin to come down almost immediately since they anticipate drug manufacturers will work quickly with the administration to lower costs.
'The president is dead serious about lowering drug prices,' officials said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
ThinkCareBelieve: Week 20 of America's Comeback Led by President Trump
Washington, DC, June 06, 2025 (GLOBE NEWSWIRE) -- Link to ThinkCareBelieve's Article: has published an article on Week 20 of America's Amazing Comeback under the Trump Administration. New investment in America manufacturing and business is bringing jobs roaring back. These are all positive indicators of solid work to put America in a good position. Despite criticism, America is getting stronger and the American people are more hopeful than they have been in a very long time. The Congressional Budget Office released a report stating that President Trump's tariffs would decrease the U.S. budget deficit by $2.8 Trillion and the trade deficit has been reduced to half. The price of eggs are 61% less, the price of gas fell again, and the stock market is strong. The border is secure and the murder rate is dropping. Inflation has evaporated, and companies are flocking to come and invest in America. The article has the latest on the return of El Salvadoran criminal Kilmar Abrego Garcia who will stand trial for heinous crimes of human trafficking and crimes against women and children. The article also has an extensive explanation of the One Big Beautiful Bill and how it will help Americans. It covers the codifying of three of President Trump's Executive Orders and DOGE being given access to the Social Security database. The article also covers the Remove Act and the Protecting Law Enforcement from Doxxing Act introduced by Senator Marsha Blackburn. The extensive work of ICE hunting down criminal aliens and taking down trafficking networks is explained. Many criminal aliens came to America to commit crimes and terrorist acts, so ICE is focused on finding them and removing them. Also covered in ThinkCareBelieve's article is President Trump's travel ban, which countries are on it and how it will be used. Also covered is the visit from recently elected German Chancellor Merz, the D-Day Celebration and the autopen investigation. is an outlook. ThinkCareBelieve's mission for Peace advocacy facilitates positive outcomes and expanded possibilities. To achieve Peace, we will find the commonalities between diverse groups and bring the focus on common needs, working together toward shared goals. Activism is an important aspect of ThinkCareBelieve, because public participation and awareness to issues needing exposure to light leads to justice. Improved transparency in government can lead to changes in policy and procedure resulting in more fluid communication between the public and the government that serves them. America needs hope right now, and Americans need to be more involved in their government. ### CONTACT: CONTACT: Joanne COMPANY: ThinkCareBelieve EMAIL: joanne@ WEB: in to access your portfolio
Wall Street Journal
33 minutes ago
- Wall Street Journal
How the Cybertruck Came to Embody Tesla's Problems
The bromance between Elon Musk and President Trump is ending at a difficult time for Tesla TSLA 3.67%increase; green up pointing triangle. The electric-vehicle maker lost roughly $150 billion of market value Thursday—its biggest ever drop—after the Tesla CEO and Trump traded insults. Sales of Teslas have slumped this year. Tariffs could disrupt the supply of key components. The sprawling Republican tax-and-spending bill would end tax credits for EV buyers. And Tesla's Cybertruck has been a disappointment. Musk set high expectations for the Cybertruck, telling investors it would be Tesla's 'best product ever.' The angular, stainless steel pickup was supposed to generate buzz for Tesla by showcasing new technology and unlocking the lucrative truck market. Instead, it has become synonymous with Musk's polarizing stint in politics, exposing some owners to graffiti or middle fingers from other drivers. And its reputation has been tarnished among Tesla fans because of a spate of recalls and manufacturing issues that have resulted in cycles of repairs. In the U.S., the company sold fewer than 40,000 Cybertrucks in 2024—well below Musk's ultimate goal of 250,000 a year. In the first quarter of 2025, Tesla sold around 7,100 Cybertrucks in the U.S., according to registration data from S&P Global Mobility. Ford's F-150 Lightning pickup outsold it. In an effort to boost sales, Tesla has rolled out lower-price versions of the truck and started offering buyers incentives such as 0% financing and free upgrades. Almost as soon as the $100,000 Cybertruck hit the road, quality problems began to multiply. Reports on social media cited cracked windshields and spotting from so-called rail dust, orange discoloration similar to rust. In its first year, Tesla recalled the truck seven times to fix dangerous defects. In March, with large metal panels falling off the trucks, the tally rose to eight. Some of the quality problems were known and documented internally before the truck went on sale, including issues with the accelerator pad and windshield wiper that later triggered recalls, said former employees who worked on the Cybertruck. But there was pressure inside Tesla to get the truck to market quickly, according to these employees. Tesla didn't respond to requests for comment. 'Elon Musk will tell you the biggest professional mistake was the falcon doors on the Model X,' said David Fick, a longtime Tesla owner who got his Cybertruck in March. He referred to the complex door design that opens upward and hinges at the roof. 'I believe that the Cybertruck is going to go down as an even bigger corporate stumble.' The retired banker in Boynton Beach, Fla., chose to wait more than a year to buy his Cybertruck, hopeful that many of the biggest issues would be identified before he drove his off the lot. 'They do a lot of bleeding-edge stuff where they rush to the market and then you're a beta tester as an owner,' Fick said. He paid about $72,000 for the car, plus $7,300 for window tinting and a custom wrap for exterior trim panels known as cant rails, covering his new car in a metallic maroon color. Soon after, Tesla recalled cant rails because they could become unglued. 'I've had tons of recalls on my Teslas over the years,' said Fick, who added that the cars are worth the hassle. 'Eighty percent were fixed by [software] updates, but these are physical things we are dealing with now.' Musk unveiled the prototype for the Cybertruck in 2019. At the time, he said it would cost $39,900, with a battery range of up to 500 miles—an ambitious combination that would be a stretch for any EV maker. Work on the vehicle was delayed a couple of years, leaving engineering and manufacturing teams with only a few months to do final testing before the trucks went to customers, former employees said. Musk tried to temper expectations around how quickly Tesla could increase production, given its unique design. 'There is always some chance that Cybertruck will flop, because it is so unlike anything else,' he wrote on social media in July 2021. Still, he promoted some of its most unusual features, including his dream of making the car amphibious. Former employees said they took Musk's social posts as orders, but the engineering proved difficult. By 2022, it was clear internally that Cybertruck wouldn't be able to meet all Musk's criteria, so engineers scrapped an early design and started over—developing a smaller, landlocked version of the truck, the people said. After about a year and a half of testing, Tesla delivered the first Cybertrucks to a dozen or so customers in late November 2023. An early version of the truck started at $100,000 and had an estimated range of 318 miles. Two months later, Tesla issued its first recall on the vehicle: a software update that required the company to increase the size of the font on a warning system used across its fleet. It was the first of three recalls that Tesla addressed on the Cybertruck through over-the-air updates to its software. Cybertruck's problems couldn't be fixed by software updates alone. In April 2024, Tesla issued a recall for the accelerator pedal. The company had received a notice from a customer complaining that the accelerator had gotten stuck. Tesla found that the pad attached to the long pedal could dislodge and get stuck in the trim above the pedal, causing the car to accelerate. An internal investigation found the issue was the result of an 'unapproved change,' in which Tesla employees used soap as a lubricant to attach the pad, according to the recall notice. Inside Tesla, the accelerator pad had been a known issue starting with the prototype, according to an employee who worked on the part. The manufacturing team also identified the part as problematic, this person said. Tesla also had problems with the Cybertruck's expansive windshield, which measured nearly 6 square feet. Sometimes the heavy glass would break, two employees said. The glass either arrived cracked from the supplier in Mexico or from handling at the Austin, Texas, facility, they said. Some owners took to social media to describe the glass cracking as soon as they drove off the lot, or while they wiped the inside of their windshield. The windshield required a large windshield wiper measuring 50 inches long. In June 2024, Tesla issued a recall on the wipers, whose motors Tesla found had been overstressed by testing. The wiper had been flagged nearly a year before, two people who worked on the Cybertruck said. It was one of the first issues identified on the vehicles, at which point it was classified as a 'gating issue,' which meant that it needed to be resolved before production could move forward. Reid Tomasko, a 25-year-old YouTube creator, took his Cybertruck on a cross-country trip, during which it performed perfectly, he said. Then came winter in New Hampshire. He was driving near his home in Lebanon, N.H., in February when a metal panel flew off the side of his truck. In March, Tesla issued a recall affecting most of the Cybertrucks it had produced—more than 46,000. The problem involved adhesive that could become brittle in extreme weather, causing exterior trim panels called cant rails to dislodge. Inspecting his truck, Tomasko said he found loose connections on almost every panel that used the adhesive, including the large pieces of stainless steel over the rear wheels, the front fender and the front doors. 'I was wondering, why are they not recalling the other panels?' Tomasko said. After replacing several panels, Tesla offered to buy back Tomasko's truck for nearly all of the $102,000 that he paid, he said. He accepted. 'I am planning on getting a newer one for cheaper soon,' he said. Write to Becky Peterson at
Yahoo
36 minutes ago
- Yahoo
Pharmaceutical company AstraZeneca sues Utah Attorney General over discount medication law
SALT LAKE CITY () — The pharmaceutical company AstraZeneca has filed a federal lawsuit against Utah Attorney General Derek Brown and Utah Insurance Commissioner Jon Pike over a recent law that is intended to allow more pharmacies to have access to drug discount programs. In a lawsuit filed May 23, AstraZeneca alleges that Utah SB 69 is unconstitutional. The law was introduced and passed in the 2025 General Assembly, and it went into effect on May 7. The law prohibits drug manufacturers from restricting pharmacies from working with 340B entities, which help pharmacies and patients access medications at a discounted price. Senator Lee responds to the Trump-Musk feud The 340B Drug Pricing Program is a that 'enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services,' according to the Health Resources and Services Administration (HRSA) website. It means that drug manufacturers participating in Medicaid agree to provide 'outpatient drugs to covered entities at significantly reduced prices.' All organizations need to be registered and enrolled in the 340B program in order to purchase discounted medications. The law that established the 340B Program, Section 340B(a)(4) of the Public Health Service Act, specified certain types of for the program, such as medical centers that serve rural and other underserved communities and clinics that specialize in particular diseases like HIV/AIDS. SB 69 expands the scope, requiring drug manufacturers to provide the discounts to third-party pharmacies that are contracting with 340B entities, and this is what AstraZeneca is claiming is unconstitutional in its lawsuit. Utah House Republicans elect new leadership members The lawsuit states that because price controls 'disincentivize innovation and destabilize markets,' Congress chose to specifically limit the types of organizations that are eligible in Section 340B. The suit notes that for-profit pharmacies like Walgreens or CVS were not included as eligible, and there have already been several federal court cases ruling that block efforts to require drug manufacturers to provide discounts to contracted pharmacies. AstraZeneca claims in its suit that SB 69 'requires pharmaceutical manufacturers to offer 340B-discounted pricing for sales at an unlimited number of contract pharmacies,' expanding 340B discounts to 'an entirely new category of transactions not covered by Section 340B itself.' The suit alleges that SB 69 directly conflicts with federal law requirements, and therefore, it cannot be enforced against Astrazeneca or other drug manufacturers. AstraZeneca is asking the court to declare SB 69 unconstitutional and to order that Utah AG Derek Brown and Insurance Commissioner Jon Pike not enforce the law against AstraZeneca. Musk floats 'The American Party' after Trump tiff Myths VS Facts: What health officials want you to know about the MMR vaccine Good4Utah Road Tour: Willard Bay State Park Lori Vallow Daybell back in court, charged with conspiracy to murder ex nephew-in-law Man charged with assault for allegedly attacking and strangling neighbor Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
